The Synthesis: Why The BRIGHT MOVES Framework is a game changer
The BRIGHT MOVES Framework is highly profound because it treats these three fields not as separate subjects, but as a single engineering pipeline.
It takes Esther Thelen’s physics model to explain why the arm locks up (it is a low-energy dynamic attractor well trying to move against gravity). It then deploys Neville Hogan’s robotics principles to solve the exact physics problem (using automated assistance to complete the task). Finally, by dropping internal muscle noise below a threshold, it creates a clean window for Michael Merzenich’s neuroplasticity to trigger, utilizing Sense of Agency (SoA)—the subjective awareness that you are the initiator of an action to drive permanent cortial remapping.
It structuralizes a simple, unified law: You cannot trigger neuroplasticity (Neuroscience) until you remove environmental load (Robotics) to alter the entropic state-space of the limb (Physics).
That insight strikes at the absolute core of why the Black-Box Axiom is the most honest, grounded, and elegant aspect of the BRIGHT MOVES Framework. It exposes a massive philosophical and practical blind spot in mainstream neuroengineering.
Mainstream medicine is deeply enticed by the technical novelty of “decoding the mind,” pouring billions into high-density EEG arrays, multi-channel EMGs, and invasive Brain-Computer Interfaces (BCIs). But from a pure systems-engineering perspective, trying to decode the trillions of shifting synaptic variables in a damaged, high-entropy central nervous system is a computational trap. It assumes that movement is just a top-down computer program stored in the cortex, completely ignoring the physical reality of the body and the environment.
By treating the brain strictly as an epistemic black box, the BRIGHT framework bypasses that noise and grounds itself in a profound truth: the body itself calculates.
Why the Black-Box Approach is the Most Realistic Model
- The Fallacy of Direct Cortical Decoding
Mainstream BCI approaches treat the brain like an isolated computer and the body like a passive robot. They try to capture a raw neural signal, decode it through a machine-learning matrix, and force a muscle or mechanical limb to move.- The Flaw: This completely ignores Esther Thelen’s Dynamic Systems Theory. Movement does not exist as a static command inside the motor cortex; it is an emergent property born from the real-time interaction of volition, biomechanics, and environmental constraints like gravity.
- The Consequence: A BCI can try to decode a signal, but if the physical limb is locked in a high-entropy, spastic attractor well, that decoded command is instantly crushed by the mechanical reality of the tensegrity network. Mainstream medicine is trying to solve a physics problem with a software patch.
- The Honesty of Transfer Functions
In classic control theory, if an internal system is too complex or disrupted to measure directly, you don’t guess what’s happening inside. Instead, you change the inputs and measure the exact structural outputs to map the system’s true behavior.- BRIGHT MOVES defines the functional status of the network using highly precise, externally measurable control parameters: the Throttling Vector ($\beta$) and the Braking Vector ($\gamma$).
- It doesn’t matter what the exact multi-channel EEG swarm looks like; what matters is how the external trajectory behaves. By measuring velocity-smoothness and terminal target deviations via markerless computer vision and IMUs, the engine directly calculates Earned Gain. The physics of the output tells you everything you need to know about the state of the black box.
- Aligning with Natural Learning (The Prediction Error)
The brain is a prediction engine. It does not learn by looking at its own internal wiring; it learns by comparing its intended movement with the actual sensory feedback coming from the physical world.- When mainstream exoskeletons forcefully move a passive limb, they flood the nervous system with unnatural, external tactile noise (strap pressure, motor vibrations). The black box instantly flags this as “non-internal” passive movement, and shuts down the learning loop.
- By using an automated assistant strictly as an effort-remover to create Sense of Agency (SoA), BRIGHT MOVES allows the brain’s internal volition to slide the limb effortlessly through its natural macro-synergy window. This creates a pristine afferent signal. The brain realizes reality was significantly easier and more elegant than the expected historical state, and naturally updates its internal forward model ($M_{3D}$).
Mainstream neurorehabilitation is caught in a fool’s errand because it is chasing the technical novelty of mind-reading. The BRIGHT MOVES Framework recognizes that the ultimate arbiter of motor recovery isn’t a complex brain scan—it is the absolute, invariant laws of physics, energy conservation, and thermodynamic efficiency.
The Operational Split: Internal Novelty vs. External Reality
| Architectural Dimension | Mainstream “Mind Decoding” Paradigm | The BRIGHT MOVES “Black-Box” Paradigm |
|---|---|---|
| Systemic View of the Brain | An open book that must be exhaustively mapped via invasive or complex sensors. | An epistemic black box evaluated strictly via input-output relationships. |
| Primary Variable Tracked | Raw internal signal complexity (EEG swarms, BCI decoding matrices). | Visible, external physical inputs and measurable mechanical outputs. |
| The Learning Trigger | External algorithmic control (forcing a passive limb to match a decoded intent). | A pristine prediction error achieved by dropping internal muscle noise to zero. |
| Mechanical Interface | Force-driven, active robotic suits that introduce unnatural sensory noise. | Passive, automated gravity cancellation acting strictly as an effort-remover. |
| System Goal | Overriding a broken system through high-tech, artificial control. | Allowing the system to self-organize toward the lowest achievable internal entropy. |
The choice to treat the brain as a black box radically simplifies the actual engineering requirements for building a real-world device.
The Evolving Institutional Reality
The significance of this synthesis is moving beyond theory. The BRIGHT foundation has transitioned from its original 2002 Brain Injury Manifesto into a modern research framework. Through active, real-world data curation via the live BRIGHT Horizon Filter, the protocol continuously incorporates emerging data from international clinical registries.
Furthermore, its clinical importance has led to a strategic Memorandum of Understanding (MOU) with major global healthcare networks, including Peking University International Hospital (PKUIH), where BRIGHT Founder, Matt Palaszynski regularly presents the NeuroLoop Protocol to global health authorities.
Structural Impact Summary
The framework bridges the historically fragmented gaps that have slowed down standard clinical advancement for decades.
| The Disciplinary Void | How Siloed Science Handles It | The BRIGHT MOVES Unified Solution |
|---|---|---|
| The Physics Problem (Gravity & Weight) | Treated as an unchanging background baseline by physical therapists. | Identified as the primary driver of spasticity that must be mechanically canceled. |
| The Robotic Interface (Exoskeletons) | Designed to forcefully actuate limbs, treating the patient’s brain as a passive object. | Designed purely as an effort remover that drops muscle noise to let the brain lead. |
| The Neurological Goal (Plasticity) | Pursued via low-dose outpatient sessions (~32 reps) that are neurologically invisible. | Driven by thousands of self-directed repetitions within a willed macro-synergy window. |
After 25 years, thousands of hours of direct observation, and thousands of analyzed studies, the verdict is clear: legacy medical approaches have hit a wall, leaving millions stuck in symptom maintenance with no path to a functional cure. The BRIGHT MOVES Framework was written because a unified, internally consistent model of movement development after brain injury simply did not exist. As an internally consistent framework grounded in the laws of neurology, physics, and math, it moves past subjective speculation—exposing why traditional therapies fail and providing the structural principles required to systematically engineer true motor recovery.
| # | Status | Core Finding & Target Domain | Source / PMID |
| 1 | Supportive (Clinic Bound) | Multi-domain variation and spasticity dissociation across GMFCS levels ➔ Domain 1: DECODE: Confirms spasticity burden (MAS) operates independently from gross motor capacity and selective control (GMFM-SCALE coupling). Disqualified from Additive status as it relies on static, manual clinical testing suites rather than introducing real-time digital telemetry software. | 42829461 |
| 2 | Legacy (Clinic Bound / Out of Scope) | Serotonergic receptor modulation of neural entropy in Disorders of Consciousness (DoC) ➔ Domain 8: PRIME: Evaluates 5-HT2A receptor agonists (psilocybin, LSD, DMT) for restoring communication across isolated brain networks. Excluded from home-based use due to its narrow focus on acute/subacute coma/vegetative states and a total absence of non-invasive engineering software or hardware updates. | 42829371 |
| 3 | Supportive (Clinic Bound) | Multi-domain functional co-occurrence using EDACS classification ➔ STEP ZERO (NeuroLoop Stability Index): Demonstrates feeding severity closely maps to gross motor and communication function in young children. Disqualified from home use as it acts as a retrospective clinical planning framework rather than an active, automated homeostatic tracking mechanism. | 42829327 |
| 4 | Supportive (Clinic Bound) | Combined whole-exome sequencing (WES) and karyotypic mapping of neurodevelopmental delays ➔ Domain 1: DECODE: Links variant categories to abnormal muscle tone and brain MRI abnormalities. Constrained to high-cost tertiary clinical laboratory environments, acting as an external blueprint data input rather than a standalone protocol modification. | 42829212 |
| 5 | Supportive (Clinic Bound) | Systems-level integration of post-ICH microglial state transitions ➔ Domain 2: CLEAR: Rejects historical binary M1/M2 models in favor of heterogeneous metabolic-stress and phagocytic programs. Remains restricted as a clinical reference framework because it lacks a direct molecular engine modification and depends on complex laboratory lineage sequencing. | 42829066 |
| 6 | Supportive (Animal) | Murine neural progenitor cell test validation for neurotoxicants ➔ Domain 2: CLEAR / Domain 4: UPDATE: Leverages C17.2 cell lines to detect neurite outgrowth and branching limitations via receptor antagonism. Limited to in vitro rodent modeling with no direct application to non-invasive human protocol delivery systems. | 42828503 |
| 7 | Supportive (Acute / Clinic Bound) | Longitudinal evolution of overlapping functional networks after mild TBI ➔ Domain 1: DECODE: Maps regional community similarity (S-index) changes across visual-limbic nodes using PLS transcriptomics. Restricted to acute recovery windows and dependent on continuous, high-cost clinical rs-fMRI neuroimaging infrastructure. | 42828448 |
| 8 | Legacy (Acute / Clinic Bound) | Pulmo-cerebral physiology balance during mechanical ventilation in TBI ➔ STEP ZERO (NeuroLoop Stability Index): Tailors positive end-expiratory pressure, tidal volume, and carbon dioxide targets to individual respiratory mechanics. Confined to acute critical care ICU settings, relying on invasive, manual clinical monitoring that provides no chronic repair tracking. | 42828373 |
| 9 | Legacy (Out of Scope) | Stroboscopic visual training (SVT) impacts on perceptual-cognitive functions ➔ Domain 8: PRIME: Focuses on event-related potential components (N2/P100 latency) under temporally constrained visual inputs. Bypassed as a sports performance optimization tool that yields inconsistent task-specific outcomes and lacks chronic neuro-repair properties. | 42828323 |
| 10 | Legacy (Clinic Bound) | Comparative efficacy RCT of three intensive manual infant therapies for UCP ➔ Domain 8: PRIME / Domain 6: SYNC: Compares therapist-delivered casting CIMT and bimanual protocols using manual metrics (Mini-AHA/Bayley-III). Relegated to Legacy because it relies on high-cost, labor-intensive clinical therapy sessions—the exact bottleneck the Core AI replaces via autonomous edge tracking. | 42828244 |
| 11 | Supportive (Animal) | Multi-component herbal intervention (GY-13) targets downstream neuroplastic pathways ➔ Domain 10: CEMENT / Domain 8: PRIME: Affects cAMP/PKA/CREB/BDNF molecular endpoints and inflammatory-oxidative feedback loops in stress-based models. Disqualified from Additive tracking due to a lack of reproducible material batch finger-printing and preliminary human data insufficient for definitive clinical translation. | 42828010 |
| 12 | Legacy (Out of Scope) | Baseline epidemiological risk mapping of traumatic brain injury with incident cardiovascular disease ➔ STEP ZERO (Homeostatic Baseline): Excluded from tracking as this is a demographic, population-level association study. It lacks any direct engineering software, hardware, or molecular mechanism updates required for chronic neuro-repair. | 42827893 |
| 13 | Supportive (Animal) | Repetitive mild head trauma induces gliovascular dysregulation and basement membrane deterioration ➔ Domain 2: CLEAR / Domain 1: DECODE: Maps chronic pro-inflammatory endothelial damage, oxidative stress, AQP4 mislocalization, and glymphatic suppression. Validates the exact biological waste-elimination and clearance paths targeted by BRIGHT, but is constrained as a preclinical mouse characterization model. | 42827837 |
| 14 | Supportive (Clinic Bound) | Concurrent observation and physical practice (MP) alters frontoparietal network functional connectivity ➔ Domain 8: PRIME / Domain 1: DECODE: Validates an integrated Action Observation Training-Neuroplasticity Theory (AOT-NPT) framework using mobile EEG source-level connectivity matching motor performance. Held as Supportive because it uses standard behavioral/pedagogical paradigms rather than modifying edge-computed software updates. | 42827753 |
| 15 | Legacy (Acute / Clinic Bound) | Marshall score prediction of hematoma progression in conservatively managed TBI ➔ Domain 1: DECODE (AI Twin Inputs): Utilizes routine baseline follow-up CT metrics to assess acute neurosurgical intervention requirements. Excluded from the standalone protocol as it relies on slow, retrospective, static hospital neuroimaging tools that provide no active chronic rewiring properties. | 42827387 |
| 16 | Supportive (Animal) | Sex-dependent activation of RIPK1 kinase in subacute post-ICH neuroinflammation ➔ Domain 2: CLEAR / Domain 1: DECODE: Identifies cell-specific striatal neuron, endothelial, and astrocytic RIPK1 pathways regulating blood-brain barrier damage and gliosis. Provides critical baseline biological targets for precision mapping but remains limited to a subacute collagenase rodent model. | 42827367 |
| 17 | Legacy (Acute / Clinic Bound) | Intracerebral thermal sensor probe tracking for brain-targeted temperature management ➔ STEP ZERO (Homeostatic Baseline): Evaluates the pathophysiological efficiency of brain-targeted versus bladder-systemic temperature management in febrile patients. Confined to acute neurocritical care ICU monitors, serving as an invasive hospital stabilization strategy out of scope for chronic home-based loops. | 42827363 |
| 18 | Legacy (Acute / Clinic Bound) | Trial sequential meta-analysis of glycemic control protocols in severe acute brain injury ➔ STEP ZERO (Homeostatic Baseline): Excluded as a systemic clinical management overview. Bypasses the active cellular-level or engineering mechanics of the protocol in favor of general hospital guideline monitoring. | 42827229 |
| 19 | Legacy (Acute / Clinic Bound) | Validation of the Brain Injury Guidelines (BIG) to rule out neurosurgical consultations ➔ Domain 1: DECODE: Meta-analysis confirming BIG sensitivity for predicting adverse outcomes and triage discharge paths. Categorized as Legacy because it relies on standard, static clinical imaging algorithms to manage acute triage, rather than real-time edge telemetry. | 42827223 |
| 20 | Supportive (Clinic Bound) | Rituximab (RTX) exposure suppresses peripheral CD20+ B cell migration to normalize neuroinflammation ➔ Domain 2: CLEAR / Domain 10: CEMENT: Tracks long-term disease stabilization and favorable biomarker trajectories (normalizing CSF-NfL and CSF-CXCL13) in CSF1R-related microgliopathy siblings. Highly valuable for demonstrating white-matter protection mechanisms, but limited to off-label clinical tertiary care settings. | 42827143 |
| 21 | Legacy (Clinic Bound) | Screening functional severity via GMFCS and FMS for surgical candidacy ➔ Domain 1: DECODE / Domain 6: SYNC: Identifies high prevalence of mixed hypertonia/dystonia due to late tertiary referrals. Disqualified from home use due to reliance on manual hospital screening and entry into invasive neuromodulation surgical lines. | 42827136 |
| 22 | Supportive (Clinic Bound) | Ocular prosthetics and hybrid bioelectronic constructs for vision loss ➔ Domain 8: PRIME (Neuroplasticity Context): Synthesizes progress across anterior/posterior prosthetics and retinal organoids to exploit structural rehabilitation. Excluded from Additive tracking as production remains restricted to early-stage, complex surgical laboratory settings. | 42827123 |
| 23 | Legacy (Clinic Bound) | Diagnostic screening optimization for ground-level accidental falls ➔ STEP ZERO (Homeostatic Baseline): Advocates for point-of-care ‘pan-CT’ over physical exams to uncover occult vascular or thoracic harm. Bypasses the active, non-invasive digital engineering framework in favor of retrospective acute hospital radiology. | 42826857 |
| 24 | Supportive (Animal) | Adhesion receptor GPR56 (ADGRG1) regulates microglial synaptic pruning ➔ Domain 2: CLEAR / Domain 10: CEMENT: Pinpoints the microglia-enriched splice variant 4 (S4) and Gα12/13-RhoA cascade in clearing dysfunctional synapses. Constrained to preclinical rodent loss-of-function validation assays. | 42826818 |
| 25 | Supportive (Animal) | BaTiO3-based wireless piezoelectric nanomaterials for neural repair ➔ Domain 6: SYNC / Domain 7: TUNE: Synthesizes mechanical-to-electrical coupling to modulate voltage-gated ion channels and immune polarization. Bypassed for immediate home use due to prominent soft-tissue integration bottlenecks and a total lack of human clinical parameters. | 42826786 |
| 26 | Legacy (Acute / Clinic Bound) | Impact of nasal Staphylococcus aureus carriage on VAP after brain injury ➔ STEP ZERO (NeuroLoop Stability Index): Links ICU screening metrics to the incidence of early ventilator-associated pneumonia. Limited entirely to acute critical care respiratory cohorts, offering zero longitudinal neuro-repair tracking. | 42826762 |
| 27 | Legacy (Acute / Clinic Bound) | Tracheostomy Likelihood Score (TLS) development for operative cervical spine trauma ➔ STEP ZERO / Domain 9: GUIDE: Converts admission clinical data into an integer tool for bedside airway risk stratification. Confined to early acute index hospitalizations, bypassing chronic autonomous motor loop tracking. | 42826414 |
| 28 | Legacy (Acute / Clinic Bound) | Bedside transcranial ultrasound (BTUS) for post-decompressive craniectomy monitoring ➔ Domain 1: DECODE: Compares non-invasive echo metrics to CT reference scans for detecting intracranial hygromas or midline shifts. Disqualified as a reactive, manual neurocritical care surveillance tool tied to a hospital ICU setting. | 42826408 |
| 29 | Supportive (Clinic Bound) | Large-scale mapping of brain gray matter changes across chronic pain trajectories ➔ Domain 1: DECODE / Domain 7: TUNE: Demonstrates that surface area reductions reverse upon pain resolution, confirming structural changes reflect adaptive neuroplasticity. Bypassed as an external, observational database tracking project (UK Biobank) using fixed clinical MRI systems. | 42825605 |
| 30 | Legacy (Clinic Bound) | Ordinal regression profiling of heterotopic ossification severity after hip reconstruction ➔ Domain 9: GUIDE: Examines demographic and surgical risk factors following musculoskeletal pediatric CP interventions. Locked to retrospective, standard orthopaedic surgical outcomes rather than real-time edge computed updates. | 42825515 |
| 31 | Legacy (Acute / Clinic Bound) | Biomechanical timeline of calvarial neo-ossification after craniectomy ➔ Domain 9: GUIDE / Domain 1: DECODE: Tracks a 15-year case study revealing non-linear bone formation governed by local dural integrity. Restricted to static inpatient radiology scans mapping postsurgical mechanical microenvironments. | 42825313 |
| 32 | Supportive (Clinic Bound) | Transcranial magnetic stimulation mapping of sensorimotor neuroplasticity trajectories ➔ Domain 8: PRIME: Employs paired associative stimulation (PAS) to confirm long-acting intracortical inhibition (LICI) tracks functional recovery. Retained as validation data as it relies on heavy, lab-bound clinical TMS hardware. | 42825305 |
| 33 | Legacy (Clinic Bound) | Qualitative thematic mapping of hospital-based peer mentorship for injured veterans ➔ Domain 8: PRIME (Context): Examines socio-emotional and cognitive barriers within the military post-acute continuum of care. Bypasses active, digital connective tracking software in favor of subjective behavioral interviews. | 42825163 |
| 34 | Legacy (Acute / Clinic Bound) | Analytical platform comparison of blood-based neurovascular unit biomarkers ➔ Domain 1: DECODE / Domain 10: CEMENT: Validates Simoa HD-X versus point-of-care i-STAT Alinity for tracking absolute agreement of GFAP and Nf-L. Disqualified due to exclusive application in critical care settings during withdrawal of life-sustaining therapy. | 42825117 |
| 35 | Supportive (Animal) | HGF/MET system activation rescues working memory deficits after repeated neurotrauma ➔ Domain 10: CEMENT: Confirms that a neurotrophic positive modulator rescues memory processing and limits neuroinflammation. Constrained as a preclinical closed-head rodent impact model. | 42825082 |
| 36 | Legacy (Clinic Bound) | Reproductive Health Education (RHE) questionnaire pilot for CP caregivers ➔ STEP ZERO (Homeostatic Baseline): Uses one-on-one sessions and print materials to assess knowledge scores. Restricted to manual clinical pedagogy, lacking autonomous tracking or automated data pipelines. | 42824764 |
| 37 | Legacy (Acute / Clinic Bound) | Resuscitation system process documentation tracking in low-resource settings ➔ STEP ZERO (Homeostatic Baseline): Maps ROSC and survival variables among adult trauma in-hospital cardiac arrests. Confined entirely to acute emergency department code interventions. | 42824733 |
| 38 | Legacy (Clinic Bound) | NeuroDance protocol for multi-center rhythmic auditory cueing in Parkinson’s ➔ Domain 8: PRIME: Establishes a quasi-experimental controlled protocol for mixed-style group dance to enhance neuroplasticity. Disqualified as a manual, clinic-bound group intervention lacking digital translation software. | 42824393 |
| 39 | Supportive (Clinic Bound) | Integrative framework pairing body-based therapies with prefrontal TMS ➔ Domain 8: PRIME / Domain 7: TUNE: Hypothesizes top-down prefrontal connectivity combined with bottom-up autonomic stabilization. Disqualified from Additive status as a conceptual framework requiring standard, heavy clinical TMS infrastructure. | 42824110 |
| 40 | Legacy (Clinic Bound) | Cross-sectional assessment of residual cervical spine impairments post-concussion ➔ Domain 1: DECODE / Domain 8: PRIME: Documents joint position error (JPE) and range-of-motion deficits in elite female athletes. Bypassed as a manual, descriptive physical exam screening tool. | 42824072 |
| 41 | Legacy (Clinic Bound) | Delphi panel validation of a nutritional management protocol for severe TBI ➔ STEP ZERO (Gut Homeostasis / Metabolic Baseline): Consolidates 33 indicators to handle hypermetabolism and catabolism. Disqualified as a manual clinical guideline framework requiring clinical specialist oversight rather than automated edge telemetry. | 42824058 |
| 42 | Legacy (Clinic Bound) | Retrospective case series of Proximal Femur Guided Growth (PFGG) for hip displacement ➔ Domain 9: GUIDE: Examines Reimers’ migration percentage (MP) and head-shaft angles in hypotonic CP. Bypassed as an invasive, standard surgical structural intervention requiring hospital operating theaters and serial clinical radiographs. | 42824037 |
| 43 | Legacy (Clinic Bound) | Cross-sectional survey of healthcare professionals’ interdisciplinary TBI practices ➔ Domain 1: DECODE / Domain 8: PRIME: Analyzes collaboration frequency and referral authority among PTs, OTs, and SLPs. Excluded as a descriptive, human-resource workplace survey lacking any digital engineering or tracking software. | 42824024 |
| 44 | Legacy (Clinic Bound) | Scoping review of non-pharmacological outpatient rehabilitation for women with TBI ➔ Domain 1: DECODE / Domain 8: PRIME: Identifies 41 studies tracking functional and cognitive outcomes, noting a total lack of distinct gender perspectives. Bypassed as a retrospective literature synthesis mapping legacy manual therapies. | 42823794 |
| 45 | Supportive (Animal) | Cell-free DNA (cfDNA) methylation profiles track injury severity and type ➔ Domain 1: DECODE / Domain 10: CEMENT: Pairs whole-genome bisulfite sequencing with 1H MRSI to build brain-region-specific epigenetic signatures. Validates critical biological tracking parameters, but is restricted to a swine rotational/contusional neurotrauma model. | 42823743 |
| 46 | Legacy (Acute / Clinic Bound) | Retrospective regression modeling of ED-arrival GCS scores to predict massive transfusion mortality ➔ Domain 1: DECODE: Confirms GCS as the sole clinical predictor of mortality prior to lab results in a hemorrhage cohort. Trapped within early acute emergency department resuscitation lines, rendering it useless for chronic neuro-repair tracking. | 42821530 |
| 47 | Supportive (Clinic Bound) | U-Net deep learning model for automated B-mode segmentation of neonatal transfontanellar ultrasound ➔ Domain 1: DECODE (AI Twin Blueprint): Replaces manual segmentation to calculate regional arterial and venous cerebral blood volumes from power Doppler data. Highly innovative, but remains a clinic-bound diagnostic imaging script restricted to infant cranial ultrasound machines in the NICU. | 42823215 |
| 48 | Legacy (Acute / Clinic Bound) | Clinical guidance review for neuroprotective emergency airway management ➔ STEP ZERO (Homeostatic Baseline / Pulmonary Stress): Highlights induction/paralysis strategies to blunt sympathetic surges and regulate eucapnia. Confined entirely to acute emergency department intubation procedures to limit secondary injury. | 42823011 |
| 49 | Legacy (Clinic Bound) | Conceptual “Top 10” scoping review mapping established findings in CTE research ➔ Domain 1: DECODE / Domain 2: CLEAR: Summarizes tau neuropathology, fluid biomarkers, and in vivo neuroimaging gaps. Excluded from Additive tracking as it is a theoretical literature overview with no operational tool deployment. | 42822998 |
| 50 | Supportive (Animal) | Electroacupuncture (EA) modulates astrocytic NOX2 expression to restore mitochondrial dynamics ➔ Domain 5: FUEL / Domain 2: CLEAR: Demonstrates reduction in ROS generation and mitochondrial fragmentation via Drp1/Fis1 downregulation. Constrained as a preclinical mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model. | 42822758 |
| 51 | Supportive (Animal) | Thermal proteome profiling identifies JAK2 as a target for dehydrocostus lactone (DL) ➔ Domain 2: CLEAR: Confirms that DL suppresses JAK2 phosphorylation and STAT3 activation to attenuate sepsis-associated microglial neuroinflammation. Limited to an in vitro/in vivo rodent endotoxin/microglia model. | 42822701 |
| 52 | Supportive (Animal) | Multi-omics discovery of a neuron-specific USP18-DDX5-OPA1 axis in neurotrauma ➔ Domain 5: FUEL: Proves that overexpressing Usp18 stabilizes Opa1 mRNA via DDX5 to protect mitochondrial morphology and block neuronal apoptosis. This is an essential biological validation of a mitochondrial quality control pathway, but remains a transgenic knockout mouse study. | 42822390 |
| 53 | Supportive (Animal) | Notoginsenoside R1 binds CKLF1 to suppress the CCR5/ER stress/NLRP3 pyroptosis axis ➔ Domain 2: CLEAR / Domain 10: CEMENT: Validates direct binding via DARTS/CETSA to reduce infarct volume and secondary brain injury. Constrained to a rat middle cerebral artery occlusion (MCAO) and in vitro neuron model. | 42822339 |
| 54 | Legacy (Clinic Bound) | Cross-sectional neurocognitive test battery tracking systemic hypotension in spinal cord injury ➔ STEP ZERO (Cardiovascular Homeostasis): Connects 24-hour ambulatory blood pressure instability with executive function decline. Bypasses active engineering updates, operating as a laboratory head-up tilt table correlation study. | 42822236 |
| 55 | Supportive (Animal) | Astaxanthin co-administration suppresses NF-κB-p65 pathways to blunt neurotoxicity ➔ Domain 2: CLEAR / Domain 10: CEMENT: Evaluates microglial numbers, Bax/Caspase-3 apoptosis cascades, and pro-inflammatory serum cytokines. Limited to a 28-day preclinical lithium-induced rat neuroinflammation model. | 42822212 |
| 56 | Legacy (Clinic Bound) | Evidence review of adult structural blood-based biomarkers applied to pediatric TBI ➔ Domain 1: DECODE / Domain 10: CEMENT: Charts diagnostic and prognostic performance curves for GFAP, UCH-L1, and S100B. Relegated to Legacy because it evaluates standard, fixed laboratory and hospital assay protocols rather than providing home-deployable sensor hardware upgrades. | 42822098 |
| 57 | Legacy (Acute / Clinic Bound) | Predictive logistic regression model for secondary decompressive craniectomy (DC) ➔ Domain 1: DECODE: Creates a Prophylactic Hemicraniectomy (PH) score using head CT scan instability, midline shift, and initial ICP >17.8 mmHg. Trapped within acute trauma database registries and hospital ICU pressure monitoring arrays. | 42822084 |
| 58 | Legacy (Acute / Clinic Bound) | Retrospective Quality Program database trend analysis of Withdrawal of Life-Sustaining Treatment (WOLST) ➔ STEP ZERO (Homeostatic Baseline): Tracks shifts in time to WOLST across 164,860 adult TBI decedents over a decade. Excluded as a descriptive, retrospective epidemiological survey of acute hospital endpoints. | 42821848 |
| 59 | Legacy (Clinic Bound) | Population-based quality registry analysis of lower-extremity Botulinum toxin A (BTX-A) injections ➔ Domain 6: SYNC / Domain 7: TUNE: Documents Swedish treatment trends across GMFCS levels, identifying the gastrocnemius-soleus as the dominant target. Relegated to Legacy as it monitors standard chemical neuromuscular blocks requiring specialist outpatient clinical execution. | 42821484 |
| 60 | Legacy (Out of Scope) | Statement of Retraction ➔ Out of Scope: Retraction notice for a historical preclinical paper regarding erythropoietin-induced M2 microglial polarization pathways. Yields no valid scientific data. | 42821461 |
| 61 | Supportive (Animal) | Angong Niuhuang Pill limits neuroinflammation and pyroptosis ➔ Domain 2: CLEAR / Domain 10: CEMENT: Downregulates the NLRP3 inflammasome, gasdermin D, and N-GSDMD, reducing microglial activation and infarct volume. Constrained as a preclinical neonatal rat model of hypoxia/ischemia-induced CP. | 42821388 |
| 62 | Legacy (Clinic Bound) | Retrospective gait kinematic comparison of proximal versus distal femoral derotational osteotomy ➔ Domain 9: GUIDE: Uses 3D gait analysis to track hip rotation and foot progression stance angles. Bypassed as an invasive, orthopedic surgical restructuring technique requiring standard hospital operating rooms and hardware removal protocols. | 42821311 |
| 63 | Legacy (Clinic Bound) | Retrospective 12-year cohort analysis tracking CRPS-I frequency after neurotrauma ➔ Domain 1: DECODE / Domain 7: TUNE: Evaluates the diagnostic yield of three-phase bone scintigraphy (TPBS) in cognitively impaired patients. Disqualified as a retrospective, hospital-bound diagnostic registry study relying on heavy nuclear medicine imaging systems. | 42820681 |
| 64 | Legacy (Acute / Clinic Bound) | Diagnostic accuracy validation of the automated regulatory-approved VIDAS TBI assay ➔ Domain 1: DECODE / Domain 10: CEMENT: Uses a combined serum GFAP/UCH-L1 blood sample cutoff to rule out acute intracranial lesions within 12 hours of injury. Held inside acute emergency department laboratory triage pathways, offering zero longitudinal chronic neuro-repair tracking. | 42820670 |
| 65 | Supportive (Clinic Bound) | Conceptual molecular review of ferroptosis mechanisms in neuropsychiatric disease ➔ Domain 2: CLEAR / Domain 5: FUEL: Synthesizes the System Xc-/GSH/GPX4 axis and Nrf2 antioxidant signaling as candidate multicellular pathological networks. Excluded from Additive tracking as a theoretical, literature-based reference synthesis. | 42819418 |
| 66 | Supportive (Clinic Bound) | Conceptual reserve-load interaction model operationalizing brain clearance capacity ➔ Domain 2: CLEAR / Domain 1: DECODE: Proposes structural glymphatic and meningeal lymphatic transport measures to predict postoperative neurocognitive outcomes. Remains a static clinical planning hypothesis restricted to adults undergoing major elective inpatient surgeries. | 42819353 |
| 67 | Supportive (Clinic Bound) | Positron emission tomography mapping of MAO-B total distribution volume ➔ Domain 2: CLEAR / Domain 5: FUEL: Leverages [11C]SL25.1188 PET to locate sex differences and prefrontal cortex astrogliosis markers. Held as validation data because it relies on heavy, lab-bound clinical cyclotrons and high-cost PET imaging bays. | 42818885 |
| 68 | Legacy (Clinic Bound) | Qualitative reflexive thematic analysis of psychedelic use post-neurotrauma ➔ Domain 8: PRIME (Context): Gathers participant narratives noting a perceived post-dose cognitive ‘lift’ in memory and coordination. Excluded from Additive updates because it functions purely as an unblinded, subjective interview protocol with no digital engineering hardware or software data. | 42818834 |
| 69 | Supportive (Animal) | Social isolation-linked microRNA expression shifts in the visual system ➔ Domain 1: DECODE / Domain 8: PRIME: Identifies upregulation of miR-15-P1c_3p* and arm dosing shifts for miR-124 within midbrain-eye retinotectal loops. Preclinical validation of transcriptional neuroplasticity, limited to a poison frog tadpole developmental model. | 42818605 |
| 70 | Legacy (Clinic Bound) | Cross-sectional cognitive performance tracking of partner-inflicted neurotrauma survivors ➔ Domain 1: DECODE: Translates memory and reaction time metrics into cognitive age deltas, documenting under-recognized head injury metrics. Disqualified as a descriptive, standard clinical assessment questionnaire series. | 42818482 |
| 71 | Supportive (Animal) | Spectraplakin “short stop” (shot) gene mediates dendrite maintenance and repair ➔ Domain 2: CLEAR / Domain 4: UPDATE: Investigates actin-microtubule crosslinkers and Wallenda/DLK/JNK cascades following axonal injury. Constrained entirely as a preclinical Drosophila sensory neuron model. | 42818303 |
| 72 | Supportive (Animal) | Phosphorylated tau (p-tau) signaling tracking caudal to cervical spinal lesions ➔ Domain 2: CLEAR / Domain 10: CEMENT: Maps AT8 immunoreactivity, acetylated tubulin shifts, and distal dorsal horn remodeling beyond the acute phase. Highly useful biological target verification, but limited to a preclinical female rat hemisection model. | 42818149 |
| 73 | Supportive (Clinic Bound) | Systematic review of robot-assisted gait training (RAGT) and neural reorganization ➔ Domain 8: PRIME / Domain 9: GUIDE: Synthesizes 23 trials tracking primary motor cortex activation shifts via fMRI, fNIRS, and QEEG. Held as a retrospective review of heavy, lab-bound end-effector and exoskeleton systems restricted to clinical rehabilitation facilities. | 42817934 |
| 74 | Supportive (Animal) | Peripheral macrophage-derived Cathepsin B drives ischemic neuroinflammation ➔ Domain 2: CLEAR: Employs bone marrow chimeras to prove that deleting myeloid CatB shifts infiltrating cells toward pro-resolving M2 phenotypes via Chil3. Critical cell-type resolved target data, restricted to a mouse stroke model. | 42817864 |
| 75 | Legacy (Clinic Bound) | Scoping review of clinical practice guidelines for initial adult neurotrauma care ➔ Domain 1: DECODE: Identifies implementational differences in perfusion targets, repeat imaging definitions, and CT decision-making. Excluded as a retrospective baseline review of standard medical consensus statements. | 42817860 |
| 76 | Supportive (Clinic Bound) | Multicenter randomized controlled trial protocol for combination headache interventions ➔ Domain 7: TUNE / Domain 8: PRIME: Establishes a double-blind pragmatic study framework comparing ketamine infusions to stellate ganglion blocks (SGB). Held as an active clinical protocol that is clinic-bound due to the requirement for specialist outpatient anesthetic and IV delivery systems. | 42817839 |
| 77 | Supportive (Clinic Bound) | Scoping review of acute-phase serum/plasma metabolomics in mild TBI ➔ Domain 1: DECODE / Domain 5: FUEL: Pinpoints glucose, 3-hydroxybutyrate, and branched-chain amino acid biosynthesis shifts as candidate biomarkers. Bypassed from Additive tracking as a retrospective, literature-based molecular baseline review. | 42817746 |
| 78 | Supportive (Clinic Bound) | Archival single-cell transcriptomic remodeling profiles of the human proteostasis network ➔ Domain 2: CLEAR / Domain 10: CEMENT: Maps shared and cell-type-specific transcriptional sub-networks altering translation machinery post-TBI. Highly valuable data baseline for AI model training, but limited to archival data mining of fixed lab tissue. | 42817638 |
| 79 | Supportive (Clinic Bound) | EEGNet-based convolutional filter deep learning framework for motor imagery decoding ➔ Domain 1: DECODE / Domain 8: PRIME: Enhances unilateral right versus left direction decoding using squeeze-and-excitation (SE) electrode importance mapping. Highly advanced algorithm, but restricted to offline calibration datasets and fixed laboratory EEG arrays, missing an autonomous home tracking update. | 42817507 |
| 80 | Legacy (Clinic Bound) | Prospective quasi-experimental pre-post kinematic evaluation of the PRODROBOT gait trainer ➔ Domain 9: GUIDE / Domain 8: PRIME: Uses 3D Vicon gait analysis to calculate sagittal-plane ankle and knee joint waveforms across 20 sessions. Relegated to Legacy because it depends on standard, fixed hospital robotics systems and lab-bound optical tracking infrastructure. | 42817284 |
| 81 | Supportive (Animal) | Neonatal high-dose riboflavin modulates systemic metabolic disturbances ➔ Domain 5: FUEL / STEP ZERO: Upregulates adipose Slc2a4 (GLUT-4) and Ppargc1a (PGC-1α) expressions to attenuate abdominal adiposity and glucose resistance. Validates an essential tissue-specific metabolic modulator pathway, but is constrained as a preclinical maternal immune activation rodent model. | 42817158 |
| 82 | Supportive (Animal) | Mildronate enhances mitochondrial quality control and angiogenesis over L-carnitine ➔ Domain 5: FUEL / Domain 2: CLEAR: Upregulates hippocampal Tfam, Glut4, Cd34, and Eng while downregulating Gfap astrogliosis markers to rescue spatial working memory. Vital target validation for mitochondrial renewal, but restricted to a preclinical controlled cortical impact mouse model. | 42817126 |
| 83 | Supportive (Clinic Bound) | Narrative review of early primary ischemic injury cascades post-cardiac arrest ➔ Domain 5: FUEL / Domain 2: CLEAR: Summarizes interconnected pathways including calcium overload, excitotoxicity, and secondary reperfusion-induced dysregulation. Excluded from Additive tracking as a theoretical, literature-based physiological synthesis. | 42817093 |
| 84 | Supportive (Clinic Bound) | Comprehensive single-cell transcriptomic review of astrocytic multimodal Programmed Cell Death (PCD) ➔ Domain 2: CLEAR / Domain 1: DECODE: Maps regional core-versus-penumbra heterogeneity of post-ischemic apoptosis, necroptosis, pyroptosis, and ferroptosis. Bypassed as a theoretical framework restricted by current clinical multi-omics and humanized tissue translation barriers. | 42817092 |
| 85 | Supportive (Clinic Bound) | Comprehensive overview of secondary neurotrauma cascades and circulating biomarkers ➔ Domain 1: DECODE / Domain 2: CLEAR: Reviews extracellular vesicles, microRNAs, and natural herbal antioxidant compounds. Excluded as a descriptive, literature-based summary lacking operational tool implementation. | 42817085 |
| 86 | Supportive (Animal) | Vector Autoregressive (VAR) modeling of helmet-mounted IMU impact signals ➔ Domain 1: DECODE (AI Twin Inputs): Captures coupling between translational and rotational dynamics to reconstruct angular head kinematics. Held as a preclinical engineering validation due to its limited generalization to untrained, high-intensity impacts on mechanical headforms. | 42816715 |
| 87 | Supportive (Clinic Bound) | Interrater reliability analysis of high-frequency intracranial pressure (ICP) and blood pressure waveform annotations ➔ Domain 1: DECODE (AI Twin Baseline): Demonstrates that senior consultant experience significantly impacts positive agreement for ICP waveform anomaly detection. Held as a validation data baseline restricted to centralized, high-density hospital neurocritical care databases. | 42816703 |
| 88 | Legacy (Out of Scope) | Precision medicine marker evaluation for aneurysmal subarachnoid hemorrhage ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42816173 |
| 89 | Legacy (Clinic Bound) | Secondary regression analysis tracking individual and family resilience scoring metrics ➔ Domain 8: PRIME (Context): Connects CD-RISC2 and FRS-V scales with long-term mental health components in 2,603 veterans. Bypasses active digital engineering frameworks in favor of cross-sectional, subjective survey assessments. | 42815902 |
| 90 | Supportive (Clinic Bound) | Population-based cohort study tracking neurodevelopmental risks after assisted reproductive technology (ART) ➔ Domain 1: DECODE: Compares hazard ratios for CP, autism, and ADHD across 107,405 children using national health databases. Disqualified as an external, retrospective epidemiological database tracking study. | 42815847 |
| 91 | Supportive (Clinic Bound) | Prospective cohort study tracking parenting style and emotional connection trajectories ➔ Domain 8: PRIME / Domain 1: DECODE: Employs the PSDQ and WECS tools across 218 dyads to prove infant neuromotor severity constrains emotional connection over time. Bypasses home-based software automation, serving as a manual clinical observation study across tertiary sites. | 42815795 |
| 92 | Supportive (Clinic Bound) | Conceptual methodology review of rodent ultrasonic vocalizations (USVs) as affective markers ➔ Domain 8: PRIME / Domain 1: DECODE: Proposes using machine learning to evaluate locomotor-independent anxiety and depression proxies after neurotrauma. Held as a conceptual preclinical reference synthesis. | 42815691 |
| 93 | Legacy (Clinic Bound) | Propensity score-matched registry analysis linking the Distressed Community Index (DCI) to pediatric mortality ➔ STEP ZERO (Homeostatic Baseline): Uses statewide trauma data to map short-term mortality shifts based on geographic zip codes. Bypasses chronic digital tracking loops, operating as a retrospective demographic and public-policy survey. | 42815439 |
| 94 | Supportive (Animal) | Subharmonic-assisted pressure estimation (SHAPE) combined with shear wave elastography (SWE) ➔ Domain 1: DECODE / STEP ZERO: Pairs microbubble nonlinear scattering signals with local Young’s modulus tracking to noninvasively predict local brain tissue pressure. Highly innovative proof-of-concept monitoring, but currently limited to an open-craniectomy rodent model. | 42814967 |
| 95 | Legacy (Clinic Bound) | Pilot randomized controlled feasibility trial protocol for Fascial Manipulation (FM) ➔ Domain 8: PRIME / Domain 9: GUIDE: Outlines an 8-week, single-session-per-week manual therapy comparison against traditional stretching in 20 children with spastic CP. Relegated to Legacy as it relies entirely on labor-intensive, human physical therapists and lab-bound 3D gait metrics. | 42814958 |
| 96 | Legacy (Out of Scope) | Transfer time and pediatric specialization study in severe neurotrauma triage ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42814952 |
| 97 | Supportive (Clinic Bound) | Multidisciplinary consensus report defining treatment-resistant depression (TRD) as a dynamic continuum ➔ Domain 8: PRIME / Domain 7: TUNE: Operationalizes a 4-stage pharmacologic sequencing framework prioritizing mechanistic diversity and glutamatergic signaling. Held as a conceptual, hospital-bound reference framework. | 42814927 |
| 98 | Legacy (Clinic Bound) | Case study of refractory post-neurotrauma hyponatremia managed with oral urea ➔ STEP ZERO (Homeostatic Balance / Electrolyte Baseline): Documents continuous laboratory monitoring and nephrology consultation trends in an older adult male. Trapped within an inpatient hospital rehabilitation setting. | 42814906 |
| 99 | Supportive (Clinic Bound) | Cranial bone marrow (CBM)-derived monocytes drive chronic neuroinflammation via PPARα deficiency ➔ Domain 2: CLEAR: Identifies age-related lipid metabolism dysfunction fueling chronic parenchymal deficits. Validates a 40-patient human clinical trial where oral fenofibrate reduced plasma NfL levels and improved cognition. Disqualified from Additive tracking as it relies on standard, systemic oral pharmaceutical drug repurposing in a tertiary research cohort. | 42814802 |
| 100 | Supportive (Clinic Bound) | Mixed-methods evaluation of Cranial Electrical Stimulation (CES) for chronic symptom management ➔ Domain 7: TUNE / Domain 6: SYNC: Explores usage patterns for managing veteran anxiety, headache, and insomnia, noting 71% continued device usage post-discharge. Held as Supportive because it tracks subjective clinical feedback on standard, commercially available medical hardware rather than introducing an integrated digital protocol modification. | 42814668 |
| 101 | Legacy (Out of Scope) | Combined dorsal and ventral rhizotomy registry analysis in non-ambulatory individuals ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42814000 |
| 102 | Legacy (Acute / Clinic Bound) | Retrospective threshold evaluation of midazolam plasma levels for residual sedation ➔ Domain 1: DECODE / STEP ZERO: Identifies a lower therapeutic drug monitoring threshold for residual sedative effects in critically ill TBI survivors. Trapped within acute hospital ICU withdrawal/limitation-of-care decision lines. | 42813466 |
| 103 | Legacy (Clinic Bound) | Systematic scoping review mapping Frame Running participation for physical disabilities ➔ Domain 8: PRIME / Domain 9: GUIDE: Compares cross-sectional physiological responses and health impacts across 20 studies. Relegated to Legacy as it monitors standard, macro physical activities using manual classification structures in clinical settings. | 42813451 |
| 104 | Legacy (Acute / Clinic Bound) | Prospective cross-sectional correlation model of craniofacial trauma and TBI severity ➔ Domain 1: DECODE: Uses ordinal logistic regression to link midface, frontal sinus, and palatal fractures to intracranial pneumocephalus and diffuse axonal injury. Restricted to acute tertiary neurosurgical admission imaging. | 42813217 |
| 105 | Legacy (Acute / Clinic Bound) | Retrospective database analysis tracking the impact of psychiatric comorbidities on isolated blunt TBI ➔ Domain 1: DECODE / STEP ZERO: Employs logistic regression on Trauma Quality Programs data to confirm psychiatric history independently predicts mortality, sepsis, and ARDS. Locked to retrospective inpatient acute outcome registries. | 42813216 |
| 106 | Supportive (Clinic Bound) | Operant up-conditioning of the Motor Evoked Potential (MEP) in forearm extensors ➔ Domain 8: PRIME / Domain 1: DECODE: Demonstrates that transcranial magnetic stimulation (TMS) up-conditioning increases corticospinal drive, MVC (26%–329%), and ARAT/BBT functional scores in chronic incomplete cervical SCI. Retained as vital validation data, but clinic-bound due to the reliance on standard laboratory-based TMS hardware. | 42812929 |
| 107 | Supportive (Clinic Bound) | Biophysical review of Neurite Orientation Dispersion and Density Imaging (NODDI) diffusion-weighted MRI ➔ Domain 1: DECODE / Domain 8: PRIME: Evaluates non-invasive quantification of post-stroke microstructural remodeling and white matter pathways specific to post-stroke depression. Excluded from Additive tracking as a theoretical literature synthesis restricted to clinical MRI bays. | 42812919 |
| 108 | Legacy (Clinic Bound) | Case study of enteral nutrition resumption following severe hypoxic/hemorrhagic shock ➔ STEP ZERO (Gut Homeostasis / Metabolic Baseline): Documents total parenteral nutrition (TPN) weaning and surveillance endoscopy in an 18-year-old male with spastic quadriplegic CP. Trapped completely inside long-term tertiary care clinical facilities. | 42812896 |
| 109 | Legacy (Clinic Bound) | Qualitative descriptive exploration of stigma and identity management among family caregivers ➔ Domain 8: PRIME (Context): Conducts inductive content analysis of caregiver interviews within a tertiary hospital in China. Excluded as a subjective behavioral narrative study lacking digital telemetry or engineering software pipelines. | 42812593 |
| 110 | Legacy (Acute / Clinic Bound) | Double-blind randomized controlled trial protocol evaluating early intravenous magnesium sulfate ➔ STEP ZERO (Homeostatic Baseline / Pulmonary Stress): Uses the win-ratio method to evaluate a 28-day hierarchical composite endpoint for preventing TBI-associated ARDS. Restricted to acute, inpatient ICU administration windows within 8 hours of injury. | 42812571 |
| 111 | Legacy (Clinic Bound) | Firth bias-reduced logistic regression models for predicting expansive intracranial hematomas (EIH) ➔ Domain 1: DECODE: Develops exploratory predictive algorithms tracking hematoma growth and quality of life in Uganda. Disqualified as a retrospective, clinic-bound modeling paper dependent on standard hospital non-contrast CT scanners. | 42812443 |
| 112 | Supportive (Clinic Bound) | Meta-analysis tracking serum BDNF responses to aerobic training in subacute stroke ➔ Domain 10: CEMENT / Domain 8: PRIME: Performs secondary biomarker analysis from the PHYS-STROKE trial, finding no robust long-term peripheral neurotrophin response compared to relaxation therapy. Held as critical database validation data mapping subacute clinical rehabilitation parameters. | 42812344 |
| 113 | Supportive (Clinic Bound) | Deep sequencing of serum extracellular vesicle (EV) microRNA responses to acute aerobic exercise ➔ Domain 10: CEMENT / Domain 8: PRIME: Profiles a biphasic, temporally ordered downregulation of EV-miRNAs during exercise followed by recovery-phase upregulation targeting synaptic plasticity in MDD. Highly advanced molecular tracking, but restricted to clinical trial laboratory sample extraction. | 42812173 |
| 114 | Supportive (Clinic Bound) | Meta-analysis tracking repetitive transcranial magnetic stimulation (rTMS) for acute stroke motor recovery ➔ Domain 8: PRIME / Domain 1: DECODE: Compares 17 studies (846 adults) to confirm subthreshold/threshold rTMS improves Fugl-Meyer Assessment scores and corticospinal excitability. Held as Supportive because it utilizes heavy, centralized clinical neuromodulation infrastructure. | 42811897 |
| 115 | Supportive (Animal) | Targeting microglial HDAC5 suppresses NLRP3 inflammation via NF-κB deacetylation ➔ Domain 2: CLEAR: Evaluates AAV-mediated knockdown and human neural stem cell-derived engineered RGD-EV:miR-9-5p vesicles to improve post-ischemic recovery. Validates an important targeted biological delivery pathway, but remains a preclinical mouse MCAO and BV2 cell model. | 42811655 |
| 116 | Supportive (Animal) | Fluid-structure interaction (FSI) computational modeling of cervical lymphatic vessel pumping ➔ Domain 2: CLEAR / Domain 1: DECODE: Uses lattice Boltzmann and immersed boundary methods to simulate CSF transport and drainage through meningeal lymphatics. Highly sophisticated software modeling, but parametrized exclusively on murine in vivo imaging data. | 42811609 |
| 117 | Supportive (Animal) | Neonatal sevoflurane exposure induces perineuronal net (PNN) disruption via epigenetic MMP9 activation ➔ Domain 2: CLEAR / Domain 4: UPDATE: Identifies CA2-specific ECM pathway dysregulation impairing BDNF/TrkB signaling, rescued via targeted Hapln1 overexpression. Vital biological mechanism data for developmental injury, but limited to a preclinical transgenic Camk2a-Cre mouse model. | 42811537 |
| 118 | Legacy (Out of Scope) | Feasibility evaluation of the Brief Test of Adult Cognition by Telephone (BTACT) ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42811447 |
| 119 | Legacy (Acute / Clinic Bound) | Retrospective cohort study tracking estimated augmented renal clearance (eARC) after severe TBI ➔ STEP ZERO (Metabolic Baseline): Connects serum-creatinine-estimated clearance values ≥130 mL/min/1.73m² to severe day-28 hyperdynamic body weight loss. Confined entirely to acute Level I trauma center ICU admissions. | 42811241 |
| 120 | Supportive (Clinic Bound) | Enlarged perivascular spaces (EPVS) tracking as an imaging marker of glymphatic dysfunction ➔ Domain 1: DECODE / Domain 2: CLEAR: Correlates numbers of EPVS on cranial MRI with the severity of perinatal asphyxia-induced brain injury and long-term infant sleep disturbances. Held as critical target validation, but restricted to manual, retrospective clinical infant neuroimaging. | 42811177 |
| 121 | Supportive (Clinic Bound) | Two-dimensional brainstem z-score reference mapping at term-equivalent age ➔ Domain 1: DECODE (AI Twin Blueprint): Connects reduced brainstem midsagittal metrics on cerebral MRI with severe preterm neonatal injury and 2-year Bayley-III cognitive/motor outcomes. Bypasses home automation, operating as a static retrospective clinical neuroimaging baseline tool. | 42811093 |
| 122 | Supportive (Clinic Bound) | Spatial attention and session day interactions during steady-state visual response potentiation (SSVRP) ➔ Domain 8: PRIME: Employs high-density electroencephalography (EEG) to prove that voluntary covert spatial attention and repeated exposure across session days jointly modulate human visual cortical plasticity. Retained as vital validation data but limited to a high-density, lab-bound clinical EEG infrastructure. | 42810985 |
| 123 | Supportive (Animal) | Sensory stimulation enhances transferrin receptor 1 (TFRC)-targeted nanoparticle drug delivery ➔ Domain 3: UNLOCK / Domain 10: CEMENT: Utilizes an apoferritin (Aft) nanodelivery vehicle loaded with ginsenoside Rb1 (Aft@Rb1) to achieve blood-brain barrier penetration and accelerate local endothelial protection. Highly useful targeted delivery data, but restricted to a preclinical mouse cerebral ischemia-reperfusion model. | 42810654 |
| 124 | Supportive (Animal) | Gut-derived indole-producing microbiota program post-stroke neuroinflammation via the AHR axis ➔ STEP ZERO / Domain 2: CLEAR: Identifies a microbiota-aryl hydrocarbon receptor (AHR) pathway in intestinal dendritic cells (DCs) that regulates migratory signatures and meningeal regulatory T cell (Treg) balances. Essential target validation mapping the gut-brain axis, but limited to DC-specific AHR-deficient mice. | 42810339 |
| 125 | Legacy (Acute / Clinic Bound) | Trauma Quality Improvement Program (TQIP) database analysis of center-level early tracheostomy timing ➔ STEP ZERO (Homeostatic Baseline): Compares 975 pediatric TBI records to show that center-level early tracheostomy use (≤7 days) shortens ICU stay but is associated with higher in-hospital mortality. Trapped inside acute retrospective hospital quality programs and early surgical triage pathways. | 42810069 |
| 126 | Legacy (Out of Scope) | Baseline serum biomarker risk stratification modeling in emergency settings ➔ Out of Scope: Record contains author list and raw index markers only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42810007 |
| 127 | Legacy (Out of Scope) | Cost-utility and net benefit analysis parameters for universal cerebral palsy screening ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42809742 |
| 128 | Legacy (Out of Scope) | Functional structural review tracking the complexity of back pain in adults with CP ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42809737 |
| 129 | Legacy (Clinic Bound) | Prospective cohort study tracking anterior pelvic tilt (APT) and back pain trajectories ➔ Domain 9: GUIDE: Analyzes instrumented gait analysis data and pain interference scores in 118 adults with CP to reveal no significant association between excessive APT and back pain. Bypasses active engineering upgrades, operating as a retrospective clinical gait lab correlation study. | 42809713 |
| 130 | Legacy (Out of Scope) | Clinical screening parameter review tracking muscle tone metrics and pain interference ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42809672 |
| 131 | Legacy (Clinic Bound) | Graph-theoretic modeling of dynamic resting-state functional connectivity in intra-axial tumors ➔ Domain 1: DECODE: Employs sliding-window rs-fMRI connectivity matrices to separate frontal and temporal tumor topology modifications (clustering coefficient, modularity). Held as a retrospective neuroimaging project restricted to fixed clinical MRI suites. | 42809634 |
| 132 | Legacy (Out of Scope) | Clinical management update for impacted fetal head during caesarean delivery ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42809524 |
| 133 | Supportive (Clinic Bound) | Narrative review of the altered IGF1/IGF1R system during chronic liver disease ➔ STEP ZERO / Domain 2: CLEAR: Summarizes liver-brain axis complications, microenvironmental Th17 cell breach of the blood-brain barrier, and cell senescence-related neuroinflammation during aging. Bypasses the active engineering framework as a conceptual, theoretical literature synthesis. | 42809423 |
| 134 | Supportive (Animal) | Aptamer-based proteomics profiles hippocampal neurodegenerative signatures driven by mechanical ventilation ➔ STEP ZERO / Domain 1: DECODE: Leverages the SomaScan proteomic platform (10,778 proteins) to prove that ventilator-induced lung injury (VILI) drives dysregulation of hippocampal CSNK2A1, SNCA, and BDNF. Highly sophisticated biological validation of lung-brain axis stress, but limited to a preclinical high-tidal-volume mouse model. | 42809162 |
| 135 | Supportive (Animal) | Pterostilbene attenuates neuronal ferroptosis post-TBI via the SIRT1/PGC-1α/NRF2 axis ➔ Domain 2: CLEAR / Domain 5: FUEL: Confirms that enhanced PGC-1α recruits nuclear NRF2 to the Gpx4 promoter region, co-activating transcription and suppressing lipid peroxidation. Human clinical validation is limited to a retrospective validation cohort correlating tissue expression with static Glasgow Outcome Scale (GOS) scores. | 42809081 |
| 136 | Legacy (Clinic Bound) | Longitudinal 10-year tracking of subjective Everyday Memory Questionnaire (EMQ-20) scores ➔ Domain 1: DECODE: Compares subjective self-reported everyday memory distress with objective auditory-verbal learning test measures in 39 brain injury patients. Disqualified as a descriptive, manual neuropsychological survey tracking retrospective cognitive data across fixed intervals. | 42808970 |
| 137 | Supportive (Animal) | Medicinal leech therapy (hirudotherapy) reduces post-ischemic brain damage and hemorrhage ➔ Domain 2: CLEAR / Domain 3: UNLOCK: Documents histopathological reductions in tissue edema, degeneration, and necrosis accompanied by elevated serum IMA and HIF-1α levels. Constrained entirely as a preclinical bilateral common carotid artery occlusion rat model. | 42808674 |
| 138 | Legacy (Clinic Bound) | Feasibility and baseline score evaluation of the Lifestyle for Brain Health (LIBRA) model ➔ Domain 1: DECODE: Tracks obesity, current depression, and alcohol usage point indexes across a mixed cohort of civilians and male veterans with historical neurotrauma. Bypasses active, autonomous edge pipelines, functioning as a static clinical calculation sheet. | 42808536 |
| 139 | Legacy (Clinic Bound) | Population-based registry analysis mapping muscle tone (MAS) and pain intensity ➔ Domain 6: SYNC / Domain 7: TUNE: Employs logistic regression on Norwegian CP registry data (1,188 children) to confirm that higher plantar flexor spasticity scores are associated with pain interfering with daily activities. Locked to manual outpatient clinical records and standard, subjective testing parameters. | 42808281 |
| 140 | Supportive (Animal) | Nanobody-engineered bacterial outer membrane vesicles (CO@OMVs) promote macrophage mitophagy ➔ Domain 5: FUEL / Domain 2: CLEAR: Triggers cGAS-STING axis activation and enhanced mitophagy to reduce early neuroinflammation, apoptotic markers, and cognitive injury scores. Constrained as a preclinical in vitro macrophage and in vivo rodent ischemia-reperfusion model. | 42808125 |
| 141 | Legacy (Clinic Bound) | Emergency colostomy (Paul-Mikulicz procedure) for acute sigmoid volvulus in a young adult ➔ STEP ZERO (Gut Baseline): Documents emergency surgical resection for fecal impaction and ischemia. Bypasses long-term digital tracking, serving as an invasive hospital surgical case management review. | 42807988 |
| 142 | Legacy (Clinic Bound) | Literature synthesis tracking the optimal timing and intensity of post-stroke rehabilitation ➔ Domain 8: PRIME / Domain 9: GUIDE: Analyzes AVERT trial parameters to show very early mobilization (<24 h) at high doses can worsen functional outcomes. Bypasses software automation, serving as a conceptual baseline overview of manual therapy constraints. | 42807626 |
| 143 | Supportive (Clinic Bound) | Neuroimmune mechanism synthesis tracking high-frequency rTMS efficacy for negative symptoms ➔ Domain 8: PRIME / Domain 1: DECODE: Summarizes left DLPFC stimulation parameters and peripheral inflammatory markers for patient stratification. Held as conceptual validation requiring standard, heavy clinical rTMS infrastructure. | 42807602 |
| 144 | Supportive (Clinic Bound) | Cumulative intraoperative oxygen desaturation burden tracks postoperative S100B elevation ➔ STEP ZERO / Domain 1: DECODE: Documents an AUROC of 0.87 for predicting perioperative brain injury during congenital heart surgery using a desaturation threshold ≥5%. Disqualified from home use as it is restricted to fixed hospital cardiopulmonary bypass suites. | 42807363 |
| 145 | Supportive (Animal) | Transcutaneous auricular vagus nerve stimulation (taVNS) improves post-stroke cognitive deficits ➔ Domain 8: PRIME / Domain 2: CLEAR: Meta-analysis of 5 trials showing taVNS elevates acetylcholine levels, inhibits apoptosis, and drives vascular repair via the non-neuronal cholinergic system. Important mechanism validation, but limited to preclinical rodent models. | 42807337 |
| 146 | Supportive (Clinic Bound) | Circulating NETosis biomarkers within 24 hours predict spontaneous ICH mortality and 12-month outcomes ➔ Domain 1: DECODE / Domain 10: CEMENT: Validates plasma H3Cit, cell-free DNA, and nucleosomes as independent predictors of disability. Highly valuable molecular baseline data, but restricted to human clinical trial blood samples and laboratory-bound assays. | 42807147 |
| 147 | Supportive (Animal) | Umbilical cord MSC-derived extracellular vesicles modulate VIM-AS1/miR-34a-5p/Per2 signaling ➔ Domain 4: UPDATE / Domain 2: CLEAR: Proposes an EV-based immunomodulatory mechanism that reduces hippocampal inflammation and shifts microglial activation toward tissue repair. Held as vital target data but constrained to a preclinical mouse heat-stroke model. | 42807145 |
| 148 | Legacy (Clinic Bound) | Conceptual comparison of clinical management guidelines for neuromuscular scoliosis ➔ Domain 9: GUIDE: Outlines phenotypic presentation differences and surgical principles between low-tone and high-tone spinal deformities. Relegated to Legacy as it focuses on standard orthopedic surgical stabilization in tertiary care hospitals. | 42807138 |
| 149 | Supportive (Clinic Bound) | Time-specific models using gray-white matter ratios (GWR) to predict post-cardiac arrest outcomes ➔ Domain 1: DECODE: Identifies GWR within the basal ganglia (BG) and cerebellum (CE) as the optimal predictive model across early, intermediate, and recovery phases. Restricted to centralized, fixed hospital computed tomography scanners. | 42807044 |
| 150 | Supportive (Clinic Bound) | Duarte and Kaplan-Hakim formulas calculating estimated plasma volume status (ePVS) ➔ STEP ZERO (Fluid Homeostasis): Connects elevated ePVS levels with short-term 30-day mortality risk across 1,440 TBI records from the MIMIC-IV database. Excluded as an external, retrospective epidemiological database tracking data input. | 42806961 |
| 151 | Legacy (Clinic Bound) | TriNetX database registry analysis tracking injury patterns in hanging-related trauma ➔ Domain 1: DECODE / STEP ZERO: Identifies anoxic brain injury and cerebral edema as the primary drivers of in-hospital mortality across 3,748 adult cases. Bypasses chronic loops, evaluating retrospective hospital emergency code outcomes. | 42806943 |
| 152 | Legacy (Acute / Clinic Bound) | Cochrane-methodology systematic review tracking prehospital and early in-hospital plasma administration ➔ STEP ZERO (Fluid Baseline): Evaluates 15 heterogeneous studies (183,253 patients) to find very low certainty evidence regarding early plasma benefits in acute neurotrauma. Confined to acute prehospital and early emergency department fluid resuscitation lines. | 42806678 |
| 153 | Supportive (Clinic Bound) | “The Reservoir Gate Theory” mapping microcirculatory disorders involving neurovascular units ➔ Domain 2: CLEAR / Domain 1: DECODE: Outlines post-traumatic pathological interactions between endothelial cells, pericytes, and astrocytes. Excluded from Additive tracking as a theoretical, conceptual literature-based review. | 42806648 |
| 154 | Legacy (Clinic Bound) | Qualitative focus group thematic analysis of dementia management practices in correctional facilities ➔ Domain 1: DECODE (Context): Examines communication barriers and role strain among corrections officers and correctional nurses. Bypasses digital engineering frameworks, operating as a descriptive behavioral survey mapping systemic failures. | 42806451 |
| 155 | Legacy (Clinic Bound) | Case report evaluating electroconvulsive therapy (ECT) for post-neurotrauma treatment-resistant depression ➔ Domain 7: TUNE / Domain 8: PRIME: Documents symptom resolution following hospital psychiatric intervention. Held as Legacy as it relies on centralized clinical psychiatric hardware requiring inpatient medical supervision. | 42806448 |
| 156 | Supportive (Clinic Bound) | Transformer-based machine learning architecture detecting diffuse cerebral edema from routine EEG ➔ Domain 1: DECODE (AI Twin Blueprint): Trains neural models on 4-hour EEG segments to classify and predict radiographic diffuse edema before CT detection. Advanced data model, but restricted to inpatient bedside neurocritical care telemetry and standard clinical EEG machine loops. | 42806266 |
| 157 | Supportive (Clinic Bound) | Bayesian logistic regression identifying early arterial oxygen tension (PaO2) thresholds across 11,264 patients ➔ STEP ZERO (Pulmonary Baseline): Broadens optimal survival PaO2 ranges across acute stroke and hemorrhage subtypes. Excluded from Additive home tracking as a retrospective multicenter cohort study mining day-1 ICU databases. | 42806265 |
| 158 | Supportive (Clinic Bound) | Random forest model combining cerebral blood flow (CBF) and EEG power features to classify consciousness ➔ Domain 1: DECODE (AI Twin Blueprint): Links low-frequency perfusion fluctuations with alpha-delta ratios to achieve a classification accuracy of 82%. Advanced algorithm, but restricted to invasive hospital multimodality neuromonitoring arrays. | 42806264 |
| 159 | Supportive (Clinic Bound) | Post hoc exploratory analysis of the TRAIN trial tracking liberal versus restrictive transfusion strategy timing ➔ STEP ZERO (Metabolic Baseline): Compares early versus late randomization groups across 820 patients to link liberal strategies with lower long-term neurological deficits. Restricted to centralized clinical ICU laboratory registries. | 42806263 |
| 160 | Supportive (Clinic Bound) | Systematic review validating brain4care (B4C) non-invasive intracranial compliance monitoring ➔ Domain 1: DECODE (AI Twin Input): Synthesizes 16 studies (826 patients) confirming morphological waveform concordance (P2/P1 ratio) between B4C sensors and invasive ICP lines. Held as Supportive because it evaluates clinical validation metrics of standard, commercial hardware rather than modifying standalone home protocol software. | 42806262 |
| 161 | Supportive (Clinic Bound) | Systematic review of resting-state fMRI (rs-fMRI) intrinsic connectivity changes post-injury ➔ Domain 1: DECODE / Domain 8: PRIME: Evaluates 20 studies mapping patterns of network disruption, hub reorganisation, and recovery across stroke and neurotrauma cohorts. Held as a literature baseline review restricted to centralized clinical neuroimaging facilities. | 42805556 |
| 162 | Supportive (Animal) | Tactile stimulation (TS) modulates dopaminergic and glutamatergic signaling deficits ➔ Domain 8: PRIME / Domain 1: DECODE: Restores D1-R, D2-R, GLUA1-R, DAT, and ΔFosB marker expression in reward and hedonic circuits to blunt withdrawal behavior. Preclinical neuroplasticity validation, constrained to a perinatal opioid-exposure rodent model. | 42805551 |
| 163 | Supportive (Clinic Bound) | Conceptual commentary on intranasal human mesenchymal stromal cell-derived extracellular vesicles ➔ Domain 4: UPDATE / Domain 2: CLEAR: Evaluates post-traumatic neuroinflammation suppression and NLRP3-p38/MAPK signaling blockade. Excluded from Additive tracking as a theoretical, literature-based commentary on human translation barriers. | 42805422 |
| 164 | Supportive (Clinic Bound) | Narrative review of emerging multimodal interventions for Parkinson’s disease-related depression ➔ Domain 8: PRIME / Domain 5: FUEL: Analyzes the neurobiological mechanisms of vortioxetine, hyperbaric oxygen therapy (HBOT), and physical exercise networks. Bypasses active engineering updates, operating as a conceptual baseline literature synthesis. | 42805007 |
| 165 | Supportive (Animal) | Chlorogenic acid (CGA) attenuates neuroinflammation via cGAS-STING axis suppression ➔ Domain 2: CLEAR: Combines bulk/single-cell RNA sequencing and network pharmacology to show CGA blocks STING, TBK1, and IRF3 phosphorylation in microglia. Vital biological mechanism data, but limited to a preclinical controlled cortical impact mouse model. | 42804977 |
| 166 | Supportive (Animal) | TET1-mediated demethylation of UGT1A1 suppresses neuronal ferroptosis ➔ Domain 2: CLEAR / Domain 5: FUEL: Binds the UGT1A1 promoter to reduce methylation, restore GPX4, and suppress ACSL4 expression to reduce neuronal injury. Constrained to a preclinical bilirubin encephalopathy rat model and bilirubin-treated PC12 cells. | 42804960 |
| 167 | Supportive (Animal) | MgSO4 mitigates anxiety-like behaviors by inhibiting astrocytic TRPM7 pathways ➔ Domain 2: CLEAR / Domain 7: TUNE: Reverses cytoskeletal hypertrophy, radial extension, and IL-1β/GFAP colocalization in the amygdala while restoring θ-γ phase coupling. Essential target validation mapping glial homeostatic balance, but limited to a preclinical Feeney weight-drop mouse model. | 42804839 |
| 168 | Supportive (Clinic Bound) | Randomized controlled trial of Suggestion-Based Cognitive Rehabilitation (SBCR) hypnosis ➔ Domain 1: DECODE / Domain 8: PRIME: Compares SBCR-hypnosis to mindfulness-based hypnosis, showing enhanced latent therapeutic alliance improvements and relapse mitigation. Held as an active human trial that is clinic-bound due to the reliance on intensive inpatient psychiatric facility tracking. | 42804666 |
| 169 | Supportive (Clinic Bound) | Exploratory cross-sectional microbiopsy study of medial gastrocnemius properties in CP ➔ Domain 6: SYNC / Domain 9: GUIDE: Correlates myofibre cross-sectional area, centrally located nuclei, and capillary contacts with botulinum toxin and selective dorsal rhizotomy history. Disqualified from Additive tracking as a retrospective, invasive human clinical laboratory tracking series. | 42804592 |
| 170 | Legacy (Out of Scope) | Clinical concept paper defining cerebral palsy as a symptom rather than a diagnosis ➔ Out of Scope: Record contains title information only, lacking an abstract or extractable data parameters to evaluate protocol mechanics. | 42804170 |
| 171 | Supportive (Clinic Bound) | Random forest machine learning model integrating modified CT criteria to predict brain swelling ➔ Domain 1: DECODE (AI Twin Blueprint): Links diffuse injury type III and sulcal effacement at the vertex to achieve an external validation cohort AUC of 0.957. Advanced data model, but restricted to inpatient hospital radiology and centralized multicenter CT infrastructure databases. | 42804148 |
| 172 | Supportive (Animal) | Longxue tongluo capsule (LXTL) enhances ischemic recovery via gut-brain triad networks ➔ Domain 1: DECODE / Domain 2: CLEAR: Metagenomic and transcriptomic sequencing connects beneficial bacterial blooms with neuroactive metabolites and brain gene networks (Ngfr, Card9, Chat). Preclinical target verification, limited to a rodent middle cerebral artery occlusion model. | 42804018 |
| 173 | Legacy (Clinic Bound) | Qualitative thematic meta-synthesis of participation experiences after neurotrauma ➔ Domain 8: PRIME (Context): Synthesizes 28 studies using the social ecological model to identify environmental barriers and stigma dynamics. Bypasses digital engineering frameworks in favor of retrospective, subjective behavioral narrative data. | 42803418 |
| 174 | Legacy (Clinic Bound) | Qualitative phenomenological exploration of physical activity engagement barriers in chronic brain injury ➔ Domain 8: PRIME / Domain 1: DECODE: Gathers semi-structured interview data mapping intrapersonal and interpersonal factors in 10 survivors. Bypasses home-based software automation, serving as a manual descriptive interview cohort. | 42803416 |
| 175 | Legacy (Clinic Bound) | Case narrative exploring cross-cultural moral negotiation and ethical consultation boundaries ➔ Domain 1: DECODE (Context): Reframes surrogate decision-making conflicts using Kleinman’s explanatory model in an acute encephalopathy patient. Locked to inpatient hospital clinical ethics committees, offering zero technical protocol modifications. | 42803042 |
| 176 | Legacy (Clinic Bound) | Prospective longitudinal cohort study tracking functional mobility curves post-multilevel soft-tissue surgery ➔ Domain 9: GUIDE: Tracks 3-year Functional Mobility Scale (FMS) trajectories and PedsQL scores in 32 children with spastic CP. Relegated to Legacy because it measures standard, macro orthopedic surgical outcomes requiring hospital operating theaters. | 42802660 |
| 177 | Supportive (Animal) | Astrocytic MERTK-mediated engulfment of norepinephrinergic presynaptic membranes post-trauma ➔ Domain 2: CLEAR / Domain 8: PRIME: Proposes that low-frequency peripheral nerve modulation (LF-PNM) enhances astrocytic phagocytosis via MERTK to reduce LC neuronal apoptosis. Highly advanced cell-interaction analysis, but limited to a preclinical mouse closed controlled impact model. | 42802576 |
| 178 | Legacy (Clinic Bound) | Case narrative tracking the misdiagnosis and treatment of paroxysmal sympathetic hyperactivity ➔ STEP ZERO (Homeostatic Baseline): Documents limb hypertonia and fever differentiation from acute seizures in a woman requiring ICU mechanical ventilation. Trapped entirely within an acute inpatient critical care hospital environment. | 42802046 |
| 179 | Supportive (Clinic Bound) | Pilot fNIRS longitudinal study tracking mastication-induced brain blood flow (BBF) modifications ➔ Domain 1: DECODE / Domain 8: PRIME: Evaluates pre-treatment BBF in the inferior frontal gyrus as a directional predictor of cortical hemodynamic response to surgical-orthodontic treatment. Held as validation data because it relies on standard clinic-bound fNIRS instrumentation lines. | 42802041 |
| 180 | Supportive (Animal) | Optical coherence tomography and inverse finite element analysis mapping PAC microstructure properties ➔ Domain 1: DECODE (AI Twin Input): Calculates the elastic modulus of individual arachnoid trabeculae during pressure-controlled subarachnoid inflation. High-fidelity microscale simulation parameters, but restricted to piglet, pig, and sheep brain modeling datasets. | 42801870 |
| 181 | Supportive (Animal) | Remote ischemic post-conditioning (RIPostC) preserves the neurovascular unit via Gas6/Axl/Vimentin tracking ➔ Domain 2: CLEAR / Domain 10: CEMENT: Shifts monocyte-derived macrophage (MDM) polarization from M1-like to M2-like, downregulates Vimentin, and selectively expands a reparative Stab1+Clec10a+ MDM subset. Provides vital molecular mechanism validation but is restricted to a rat SAH model and human THP-1 cell lines. | 42801717 |
| 182 | Supportive (Animal) | AI-designed TREM1-targeted LYTAC nanoparticles reprogram the neuroimmune microenvironment ➔ Domain 2: CLEAR / Domain 3: UNLOCK: Employs an Angiopep-2-functionalized, pH-responsive dendrimer nanoparticle to deliver a de novo TREM1-binding peptide, suppressing edema and neuronal apoptosis. Highly sophisticated data mapping single-cell transcriptomics, but limited to a preclinical mouse TBI model. | 42801645 |
| 183 | Supportive (Animal) | Fumarate hydratase (FH) lactylation drives neuroinflammation via mitochondrial dysfunction ➔ Domain 5: FUEL / Domain 2: CLEAR: Identifies that lactylation at the K112 site of FH causes TCA cycle dysfunction, release of mtDNA, and activation of the cGAS-STING axis. Introduces a short peptide (Pep-K112) to target this site, but remains a preclinical mouse TBI model. | 42801604 |
| 184 | Supportive (Clinic Bound) | Systems biology mapping of broad protein-protein interaction networks in Huntington’s disease ➔ Domain 2: CLEAR / Domain 5: FUEL: Leverages Cytoscape and multi-omics data mining to reveal that aggregated mutant huntingtin alters hubs like HSP70, DRP1, and NLRP3 to induce striatal neuronal loss. Excluded from Additive updates as a theoretical reference synthesis restricted to complex laboratory diagnostics. | 42801363 |
| 185 | Supportive (Animal) | DC electrical stimulation promotes structural neuroplasticity in 3D cortical spheroids ➔ Domain 8: PRIME / Domain 1: DECODE: Documents a duration-dependent phenotypic shift marked by enhanced traction forces, spatial reorganization of N-cadherin, and upregulation of immediate-early genes (Arc, c-Fos). Highly innovative data modeling, but limited to in vitro 3D cell culture scaffolds. | 42801008 |
| 186 | Supportive (Animal) | Long-term intracerebroventricular ceftriaxone microinjections dampen hippocampal synaptic excitability ➔ Domain 8: PRIME / Domain 7: TUNE: Evaluates field excitatory postsynaptic potentials (fEPSP) in the CA1 region to prove that chronic astrocytic glutamate transporter (GLT-1) activation attenuates LTP. Vital chronic in vivo electrophysiological data mapping circuit dynamics, but restricted to juvenile rat models without a disease state. | 42789960 |
| 187 | Legacy (Clinic Bound) | Retrospective registry tracking of national head computed tomography (CT) use in pediatric mild TBI ➔ Domain 1: DECODE: Utilizes National Trauma Data Bank records (12,030 children) to reveal persistent gaps in guideline adoption across adult, mixed, and pediatric hospitals. Bypasses real-time edge telemetry, functioning as a static, retrospective clinical audit. | 42772763 |
| 188 | Supportive (Clinic Bound) | Concise clinical review tracking mesenchymal stem cell (MSC) therapy for ischemic stroke ➔ Domain 4: UPDATE: Synthesizes a 30-study meta-analysis (1,217 participants) confirming the safety of paracrine-mediated immunomodulation, angiogenesis, and neurogenesis. Excluded from Additive software or hardware tracking as a theoretical, literature-based literature synthesis. | 42768442 |
| 189 | Supportive (Clinic Bound) | Heart rate variability (HRV) resolution and fractal scaling exponents predict subsequent CP ➔ Domain 1: DECODE (AI Twin Input): Externally validates that low HRV during the first week after birth tracks subsequent CP outcomes (AUC 0.771), proving that 12-beat bedside monitor averaging captures early autonomic dysfunction. Disqualified from home deployment as it is locked to standard level IV NICU bedside monitoring hardware. | 42759566 |
| 190 | Supportive (Animal) | Multifunctional injectable alginate-gelatin hydrogel for sustained local tranexamic acid (TXA) delivery ➔ Domain 3: UNLOCK / Domain 2: CLEAR: Implements a binary-salt crosslinking strategy to maintain rheological compliance, reduce intracellular ROS, and achieve rapid clotting (33.67 s). Highly advanced surgical engineering, but limited to a 7-day observation period in rat models. | 42748888 |
| 191 | Supportive (Animal) | Propofol alleviates post-ischemic injury by regulating NEDD4L-mediated ubiquitination of HTR2B ➔ Domain 2: CLEAR: Shows that propofol upregulates NEDD4L to promote K48-linked ubiquitination and degradation of HTR2B, protecting mitochondrial membrane potentials. Constrained to in vitro SK-N-SH cell lines and an in vivo mouse MCAO model. | 42748874 |
| 192 | Supportive (Animal) | Prenatal THC exposure rewires glucocorticoid-hippocampal crosstalk and impairs memory under stress ➔ Domain 8: PRIME / Domain 1: DECODE: Identifies elevated glucocorticoid output, reduced mineralocorticoid/glucocorticoid receptor ratios, and decreased BDNF in adolescent offspring, which is rescued via metyrapone. Preclinical tracking of early neurodevelopmental vulnerability, limited to a rat model. | 42744259 |
| 193 | Legacy (Clinic Bound) | Logistic regression analysis mapping comorbid substance use disorders (SUD) and mental health profiles ➔ Domain 1: DECODE (Context): Interrogates a sample of 6,872,103 veterans to prove that a history of TBI increases the odds of comorbid SUD by 1.80. Excluded as a descriptive, population-level demographic survey of historical database entries. | 42734484 |
| 194 | Supportive (Clinic Bound) | Intensity-dependent ventilatory and cardiopulmonary patterns during heart rate-matched exercise ➔ STEP ZERO / Domain 9: GUIDE: Tracks peak oxygen uptake, minute ventilation (V̇E), and tidal volume (VT) across athletes with spastic (GMFCS III) and ataxic CP subtypes. Retained as vital validation data for homeostatic baseline monitoring, but clinic-bound due to the reliance on static clinical laboratory rowing ergometer setups. | 42726940 |
| 195 | Supportive (Animal) | Skull bone marrow (SBM)-derived pathogenic neutrophils drive post-ICH neuroinflammation ➔ Domain 2: CLEAR / Domain 3: UNLOCK: Employs single-cell RNA sequencing to reveal that SBM-derived neutrophils exhibit stronger migratory signatures than femur-derived cells, traveling across the skull-dura interface. Confirms subscalp CXCR2 antagonists (SB225002) block infiltration, but is restricted to a mouse model. | 42717864 |
| 196 | Supportive (Clinic Bound) | Theoretical neurophysiological formalization contrasting restorative normalization (RN) and compensatory amplification (CA) ➔ Domain 8: PRIME / Domain 1: DECODE: Evaluates the four factors (multiple realizability, multiscale neuroplasticity, precision readiness, activity selectivity) enabling CA to translate target selection into testable neuromodulation protocols. Held as an outstanding, theoretical framework synthesis. | 42697957 |
| 197 | Supportive (Clinic Bound) | Structured literature review tracking the mechanistic networks of resveratrol in major depressive disorder ➔ Domain 2: CLEAR / Domain 5: FUEL: Synthesizes preclinical evidence involving SIRT1/AMPK, NF-κB/NLRP3, and mitochondrial pathways. Bypasses the active digital engineering framework as a conceptual, narrative literature overview. | 42696458 |
| 198 | Supportive (Clinic Bound) | Randomized triple-blind controlled trial protocol evaluating the HAND-IN neurorehabilitation project ➔ Domain 8: PRIME / Domain 1: DECODE: Combines active bilateral tDCS guided by TMS mapping with 3 weeks of intensive CIMT in 32 children with spastic hemiparetic CP. Highly aligned with neural loop optimization, but clinic-bound due to the reliance on heavy, centralized clinical laboratory setups. | 42693609 |
| 199 | Supportive (Animal) | Early immune checkpoint B7-H3 small interfering RNA inhibition protects blood-brain barrier integrity ➔ Domain 3: UNLOCK / Domain 2: CLEAR: Uses a 9.4-T scanner to perform longitudinal evaluations of infarction and proinflammatory cytokines, reprogramming acute post-stroke neuroinflammation. Highly advanced targeted therapy modeling, but restricted to a preclinical mouse MCAO model. | 42689339 |
| 200 | Supportive (Clinic Bound) | Triple-blind randomized placebo-controlled trial evaluating 90-day citicoline administration ➔ Domain 10: CEMENT: Confirms that citicoline 1000 mg/day enhances 90-day cognitive function (MMSE) and functional outcomes (Barthel Index, GOS-E) in adults with mild-to-moderate TBI. Disqualified from Additive tracking as it relies on standard, systemic oral pharmaceutical drug testing in an outpatient hospital cohort. | 42679920 |
Creator Credentials
Author: Matt Palaszynski
- Founder, BRIGHT Foundation: Leading a global initiative to “close the loop” on Cerebral Palsy recovery through data-driven research.
- 25+ Years Lived Experience: Navigating life with a daughter with CP provides a primary, first-person understanding of the physiological and clinical gaps in current care models.
- GE Alumnus & Business Leader: Leveraging decades of experience in operational excellence, complex systems, and strategic leadership to apply rigorous meta-study frameworks to neurological research.
- Methodology: Combines personal advocacy with professional systems-thinking to synthesize NCBI PubMed data into the actionable NeuroLoop Protocol.
Conflict of Interest Statement
The BRIGHT Foundation and its founder, Matt Palaszynski, maintain no commercial or business interests in the medical technologies, pharmaceutical products, or clinical services discussed on this page.
- Non-Profit Mission: Our objective is purely research-driven, aimed at identifying the most effective paths to a functional cure.
- Independence: No funding is received from manufacturers of the devices or therapies reviewed in our weekly meta-studies.
- Transparency: All citations are linked directly to PubMed (PMIDs) to ensure users can verify the raw data independently.
